Adverse Brain Health Outcomes Increased for Sexual, Gender Minority Groups
FRIDAY, Sept. 27, 2024 -- Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study published online Sept. 25 in Neurology.
Shufan Huo, M.D., Ph.D., from the Yale University School of Medicine in New Haven, Connecticut, and colleagues conducted a cross-sectional study in the All of Us Research Program to examine whether SGM persons have a higher risk for adverse brain health outcomes compared to cisgender straight (non-SGM) individuals. The primary outcome, assessed using electronic health record data and self-report, was a composite of stroke, dementia, and late-life depression.
The analyses included 393,041 U.S. adults with available information on sexual orientation and gender identity, 39,632 (10 percent) of whom belonged to SGM groups. Of these, 97 and 11 percent belonged to a sexual minority and gender minority, respectively. The researchers found that SGM individuals had increased odds of the brain health composite outcome compared with non-SGM persons (odds ratio, 1.15). These results persisted across sexual and gender minorities separately. Assessing individual diseases, all SGM groups had increased odds of dementia and late-life depression (odds ratio, 1.14 and 1.27, respectively), while transgender women had higher odds of stroke (odds ratio, 1.68).
"Our results highlight the importance of continued investigation into these disparities to ultimately inform future policy decisions toward more inclusive and equitable neurologic health care," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.